CD274 and meningioma: Since the immunotherapy including immune checkpoint inhibitor (PD-L1/PD-1 inhibitor) and CAR-T have demonstrated their antitumor efficacy in solid tumors, we next investigated the immune cell infiltration and PD-L1 expression in meningiomas.